Allegro Ophthalmics allegroeye.com


Public list: Pharma Startups (4743) Eye Health (699)

Allegro Ophthalmics is working to establish Integrin Peptide Therapy as a pharmaceutical category for the treatment of vitreo-retinal diseases. Allegro's lead investigational drug, Luminate, is currently in Phase 2 studies and has the potential to reduce the current burden of intravitreal injections and to be a viable option for patients with diabetic macular edema and wet age-related macular degeneration.

Allegro Ophthalmics is working to establish Integrin Peptide Therapy as a pharmaceutical category for the treatment of vitreo-retinal diseases. Allegro's lead investigational drug, Luminate, is currently in Phase 2 studies and has the potential to re...Show all

Company (Alive / Active)

Phone: 949-940-8130

Fax:

31473 Rancho Viejo Road
Suite 204
San Juan Capistrano, 92675
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Allegro Ophthalmics $41M Dec 21, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Allegro Ophthalmics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)